Pain Management in Patients with Obesity: Clinician Insights on Balancing Pharmacological & Lifestyle Approaches
Monu Khanna, MD, discusses common medications, non-drug strategies, and holistic approaches to improve outcomes.
Donanemab Label Revised: New Dosing Schedule Approved for Early Alzheimer’s Treatment
The FDA approved updated dosing for donanemab in early Alzheimer disease, reducing ARIA-E risk by 41% without compromising efficacy.
Quest Will Offer FDA-Cleared Fujirebio Blood Test to Detect Alzheimer Disease
The Fujirebio in-vitro diagnostic has shown positive and negative predictive values of 92% and 97%, respectively, for early AD detection and will be offered by end of summer.
GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns
GLP-1 medications are transforming obesity medicine but strong evidence points to a need for integrating nutrition and lifestyle support for lasting weight loss and health benefits.
Diabetes Guidelines are Plentiful. The New One from the ACLM Can Support Them All
Richard Rosenfeld, MD, MPH, MBA, explains how clinical guidelines for diabetes remission from the American College of Lifestyle Medicine differ from and augment existing recommendations.
Unnecessary Cancer Screenings in the US Persist Long After Guidelines Shift: Daily Dose
Your daily dose of the clinical news you may have missed.
Monu Khanna, MD: Practical Pain Management Tips for Patients with Obesity
Dr Khanna discusses dosing challenges, metabolic issues, and potential complications from medications like acetaminophen.
The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment
Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.
New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies
New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.
5 Fall Prevention Tips for Your Older Adult Patients: Refresher for Primary Care
Exercise and strength/balance training are keys to protect against falls but careful assessments at each clinic visit can uncover many other risks you'll want to address.
Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings
Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.
Lifestyle Interventions for Treatment and Remission of Prediabetes and T2D: There's a Guideline for That?
The American College of Lifestyle Medicine recently published "that guideline," and lead author Richard Rosenfeld, MD, MPH, MBA, says the timing was right.
Obesity and Type 2 Diabetes: Expert Shares 4 Pillars of Management
Caissa Troutman, MD, discusses how clinicians can tailor management plans to reduce risk of developing T2D in patients with obesity.
Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds
A new study found racial disparities in COVID-19 antiviral prescribing, with clinic site, test type, and telehealth use explaining up to half the gap for Black and Latino patients.
Intranasal COVID-19 Vaccine Found Safe and Immunogenic in Open Label Phase 1 Clinical Trial
Among recipients of high-dose CVXGA, relative vaccine effectiveness was 67.8% against symptomatic COVID infection at a median 7.3 months post-vaccination.
Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial
ADA 2025: Dapiglutide showed promising safety and weight loss results in a phase 1b trial, targeting obesity and inflammation with once-weekly dosing.
Apogee Hopes Raised by Phase 2 Data for APG777 to be a Best-In-Class for Atopic Dermatitis
The investigational IL-13 inhibitor showed topline EASI-75 of 66.9% and reduced injection frequency in part A of the APEX phase 2 clinical trial. i
Fad Diets and TikTok Nutrition Influencers: 90% of Clinicians Are Concerned, Survey Says
Social media support for the Keto diet and raves about the next best dietary supplement worry HCPs; they also feel their own nutrition education is subpar.
Real-World Weight Loss With GLP-1s Falls Short of Trial Results: Daily Dose
Long-Term Data Support Roflumilast Cream for Pediatric Atopic Dermatitis: Daily Dose
